Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC007528 | Panoply™ Human IL10 Knockdown Stable Cell Line | Inquiry |
| CSC-SC007528 | Panoply™ Human IL10 Over-expressing Stable Cell Line | Inquiry |
| CLOE-1091 | Human IL10 HEK293 Cell Lysate | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD07994Z | Human IL10 adenoviral particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH343792 | shRNA set against Human MPE (NM_001039396.1) | Inquiry |
| SHH318097 | shRNA set against Mouse IL10 (NM_010548.2) | Inquiry |
| SHH318101 | shRNA set against Rat IL10 (NM_012854.2) | Inquiry |
| SHH343796 | shRNA set against Mouse MPE (NM_010821.1) | Inquiry |
| SHH343800 | shRNA set against Rat MPE (NM_022617.1) | Inquiry |
| SHL170570 | shRNA set against Human IL10(NM_000572.2) | Inquiry |
| SHW000174 | shRNA set against Chicken IL10 (NM_001004414) | Inquiry |
| SHW008807 | shRNA set against Danio rerio IL10 (NM_001020785) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDCB157246 | Mouse IL10 ORF clone (NM_010548.1) | Inquiry |
| CDCB170282 | Danio rerio IL10 ORF Clone (NM_001020785) | Inquiry |
| CDFH009131 | Human IL10 cDNA Clone(NM_000572.2) | Inquiry |
| CDFR010710 | Rat Il10 cDNA Clone(NM_012854.2) | Inquiry |
| MiUTR1H-04870 | IL10 miRNA 3'UTR clone | Inquiry |
| MiUTR1R-02620 | IL10 miRNA 3'UTR clone | Inquiry |
| CDCB156868 | Canine IL10 ORF clone (NM_001003077.1) | Inquiry |
| CDCB161649 | Chicken IL10 ORF Clone (NM_001004414) | Inquiry |
| CDCB180521 | Rabbit IL10 ORF clone (XM_008268045.1) | Inquiry |
| CDCL184730 | Human IL10 ORF clone(NM_000572.2) | Inquiry |
| CDCL184732 | Rat IL10 ORF clone(NM_012854.2) | Inquiry |
| CDCR249201 | Mouse Il10 ORF Clone(NM_010548.2) | Inquiry |
| CDCS405758 | Human IL10 ORF Clone (BC104252) | Inquiry |
IL-10 is known as an-inflammatory cytokine and produced by various cells including immune cells like T and B cells, and tumor cell lines. Several reports have demonstrated that IL-10 is involved in many important physiological processes like the inhibition of antigen presentation and the release of proinflammatory cytokines, regulation of the proliferation and differentiation of several immune cell types.
IL-10 signaling
It has been shown that IL-10 serve as an anti-inflammatory cytokine via binding with IL-10 receptor, which is expressed on a variety of cells, particularly immune cells. Previous structure studies have shown that IL-10R is composed of 2 α chains and 2 β chains. Those two chains have distinct role that α binds with IL-10, and β works in signal transduction with access to IL-10. Studies have shown that binding of IL-10 to IL-10 receptor results in activation of kinase-1 and tyrosine kinase-2, which leads to phosphorylation of IL-10 receptor in turn. Phosphorylated IL-10R binds with signal transducer and activator of transcription (STAT)-3, resulting in phosphorylation of STAT3 by receptor-associated Janus activated kinases and the activation of downstream target genes such as the expression of suppressor of cytokine signaling (SOCS)-3 gene, which inhibits the production of proinflammatory cytokines and JAK/STAT-dependent signaling, and ultimately the expression of anti-inflammatory effectors. The whole signaling pathway is shown as Figure 1.
Figure 1. Signaling pathway of IL-10. (Kumar S, et al.)
Roles of IL-10 in related diseases
Accumulating evidences have demonstrated that IL-10 is implicated with various diseases including irritable bowel syndrome (IBS), obesity, Alzheimer’s disease (AD), cervical carcinoma and so on. Thus, it might be a potent anti-inflammatory biological therapy target for those diseases.
IL-10 and AD
Recently, some reports have considered that an imbalance between pro-inflammatory and anti-inflammatory cytokines may be an important phenomenon in AD. Thus, IL-10, an anti-inflammatory cytokine, must plays a crucial role in AD. Indeed, studies with transgenic AD mouse models have demonstrated that IL-10 significantly reduced neuroinflammation, enhanced neurogenesis and improved spatial cognitive dysfunction. Those findings indicated that IL-10 may have a positive function in neuroinflammation, cognitive dysfunction and neurodegeneration. Moreover, several studies also focus on the relationship between the functional polymorphisms of the IL-10 gene and AD, and conclude that the IL-10 polymorphisms are an additive and independent risk factor for AD.
IL-10 and cervical carcinoma
Studies have found that IL-10 production can be induced and maintained by various cells such as infected keratinocytes, some subsets of dendritic cells (DC) and tumor cells in the condition of HPV infection. Additionally, a number of data have shown that the HPV E2, E6 and E7 proteins act over IL-10 gene transcription, leading to the increasing of IL-10 levels, while IL-10 stimulates HPV E6 and E7 expression like Figure 2. Therefore, there is a vicious cycle between IL-10 and HPV, which might be contributed to the progression of a simple HPV infection to SIL or cervical cancer.
Figure 2. The interplay between IL-10 and HPV. (Berti F C, et al.)
In addition to the diseases mentioned above, IL-10 also has a complex regulation in others virus infection. A better understanding about IL-10 effects on the different physiological and pathological processes will be contributed to the further studies that IL-10 is function as a therapeutic target.
References: